High-dose ifosfamide with mesna uroprotection: a phase I study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A D EliasK H Antman

Abstract

Phase II trials of ifosfamide have been performed with standard doses of 5 to 8 g/m2/course. In this phase I study, 29 patients were treated with a 4-day continuous infusion ifosfamide to determine the maximum-tolerated dose and the nonhematologic dose-limiting toxicity. Autologous bone marrow support was to have been used for the subsequent dose level if granulocytes were more than 500/microL for more than 14 days in two of two to five patients at a given dose level. Doses were escalated from 8 to 18 g/m2 ifosfamide. Mesna was given at an equivalent dose by continuous infusion for 5 days. At the 18 g/m2 dose level, dose-limiting renal insufficiency and a median of 11 days (range, 8 to 18 days) of granulocytopenia (less than 500/microL) were observed. Thus, autologous bone marrow reinfusion ws not used. The duration of myelosuppression, the frequency and severity of mucositis, and renal tubular acidosis were all dose-dependent. Mild to moderate CNS toxicity also appeared to be related to dose; however, severe CNS toxicity (transient confusion, hallucinations, and somnolence) was observed sporadically at both low- and high-dose levels. Transient hematuria (greater than 50 red blood cells [RBCs]/high power field) occurred once bu...Continue Reading

Citations

Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·W P BradeC E Araujo
Mar 1, 1994·Cancer·J R DiMaggioD Schapira
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·E C BrainJ L Misset
Dec 10, 1999·Pediatric Transplantation·J E Sanders
Oct 27, 2004·Pediatric Blood & Cancer·Su Gülsün BerrakNorman Jaffe
Mar 2, 2006·American Journal of Veterinary Research·Kenneth M RassnickRodney L Page
Jan 4, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Tsuneharu MikiUNKNOWN Japan Blood Cell Transplantation Study Group for Testicular Germ Cell Tumor
Mar 21, 2013·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·YanPing ZhangKirk S Culotta
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·A D EliasE Frei
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·T CernyA Küpfer
Nov 1, 1992·Acta Neurologica Scandinavica·O MerimskyS Chaitchik
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L HensleyD G Pfister
Oct 31, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Y BlayP Biron
Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·T M LoefflerT U Hausamen
Jan 1, 1995·Journal of Cancer Research and Clinical Oncology·H J KeizerF J Cleton
Jan 1, 1994·Medical and Pediatric Oncology·C S BruggersR Delong
Oct 6, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M M MoraisR A Ribeiro
Jun 12, 2002·Current Treatment Options in Oncology·F C EilberF R Eilber
Aug 20, 2002·The Oncologist·Alexander I Spira, David S Ettinger
Dec 1, 1995·The Annals of Pharmacotherapy·A Bhardwaj, P S Badesha
Jul 10, 2009·Cancer Chemotherapy and Pharmacology·Romain CoriatFrançois Goldwasser
Jan 30, 2015·Clinical Sarcoma Research·Roberta SanfilippoPaolo Giovanni Casali
Aug 1, 1991·Cancer·R Mazanet, K H Antman
Mar 14, 1998·American Journal of Clinical Oncology·M W Ben ArushN Haim
Oct 3, 2014·Toxicologic Pathology·Myrtle DavisToufan Parman
Aug 11, 2017·Therapeutic Advances in Medical Oncology·Gino K InWilliam W Tseng
Oct 6, 2006·Expert Review of Anticancer Therapy·Robin L Jones, Michael S Ewer
Dec 28, 1999·Medical and Pediatric Oncology·J FelgenhauerJ S Miser

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A D EliasL Schnipper
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
T C SheaW D Henner
© 2021 Meta ULC. All rights reserved